Source:http://linkedlifedata.com/resource/pubmed/id/10959644
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005149,
umls-concept:C0019682,
umls-concept:C0019693,
umls-concept:C0019699,
umls-concept:C0020835,
umls-concept:C0032105,
umls-concept:C0035668,
umls-concept:C0205171,
umls-concept:C0220901,
umls-concept:C0242485,
umls-concept:C0243009,
umls-concept:C0441889,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C2587213
|
pubmed:issue |
4
|
pubmed:dateCreated |
2000-12-13
|
pubmed:abstractText |
The interrelationships between the CD4 lymphocyte count, plasma viral load [human immunodeficiency virus (HIV) RNA], beta-2-microglobulin (beta2-M) and immunoglobulin A (IgA) and the mortality risk was explored in 234 HIV-infected individuals (median CD4 count 230 cells/mm3, range 1-1,247). Product-moment correlation analysis was used to study the association between beta2-M, IgA and HIV RNA. A proportional hazards Cox model was used to estimate the relative hazard (RH) of death. Both beta2-M (r = 0.49, p < 0.0001) and IgA (r = 0.42, p < 0.0001) were positively correlated with HIV RNA. High beta2-M levels were associated with an increased risk of death in both univariate Cox analysis and after adjustment for HIV RNA, CD4 lymphocyte count and age [RH = 1.16 per 100 nmol/l higher beta2-M, 95% confidence interval (CI) 1.05-1.27]. Raised IgA levels were associated with shorter survival in individuals with a CD4 count above 50 cells/mm3 in univariate analysis as well as after adjusting for age and CD4 lymphocyte count (RH = 1.19 per 10 micromol/l higher IgA, 95% CI 1.01-1.39). However, this association was no longer significant after further adjusting for HIV RNA. In conclusion, beta2-M levels provided additional prognostic information for survival to the information obtained by CD4 count and HIV RNA levels, whereas serum IgA only was a weak prognostic marker in this fairly progressed cohort.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0036-5548
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
371-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10959644-Adult,
pubmed-meshheading:10959644-Aged,
pubmed-meshheading:10959644-CD4 Lymphocyte Count,
pubmed-meshheading:10959644-Female,
pubmed-meshheading:10959644-HIV Infections,
pubmed-meshheading:10959644-Humans,
pubmed-meshheading:10959644-Immunoglobulin A,
pubmed-meshheading:10959644-Male,
pubmed-meshheading:10959644-Middle Aged,
pubmed-meshheading:10959644-Prognosis,
pubmed-meshheading:10959644-RNA, Viral,
pubmed-meshheading:10959644-beta 2-Microglobulin
|
pubmed:year |
2000
|
pubmed:articleTitle |
Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels.
|
pubmed:affiliation |
Department of Infectious Diseases, Finsen Centre, Rigshospitalet, Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|